Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.
Surg Oncol Clin N Am
; 26(1): 17-31, 2017 01.
Article
en En
| MEDLINE
| ID: mdl-27889034
ABSTRACT
Anal cancer is an increasingly common non-AIDS-defining cancer among individuals infected with the human immunodeficiency virus (HIV). It is associated with human papillomavirus (HPV). HPV16 is the most common genotype detected in anal cancers. The HPV types detected in anal cancer are included in the 9-valent vaccine. HPV vaccines have demonstrated efficacy in reducing anal precancerous lesions in HIV-infected individuals. Standard treatment has been fluorouracil and mitomycin (or cisplatin) plus radiation. Continued studies are needed to test new treatment strategies in HIV-infected patients with anal cancer to determine which treatment protocols provide the best therapeutic index.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias del Ano
/
Seropositividad para VIH
/
Infecciones por Papillomavirus
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Surg Oncol Clin N Am
Asunto de la revista:
NEOPLASIAS
Año:
2017
Tipo del documento:
Article
País de afiliación:
Estados Unidos